Dicerna Pharmaceuticals

Entry	Author	Date	Location
Boston Xconomists and Area Innovators Gather for Special Xconomy Event: The Photos	Erin Kutz	10/13/11	Boston
Tokai Snaps Up $23M From Novartis and Apple Tree to Challenge Leaders in Prostate Cancer	Luke Timmerman	09/20/11	Boston
Alnylam CEO Looks to the Future, Dicerna Plumps Up Kyowa Hakko Pact, Momenta Sells $57.4M Stock Offering, & More Boston-Area Life Sciences News	Erin Kutz	12/10/10	Boston
Dicerna Expands Kyowa Hakko Pact	Ryan McBride	12/07/10	Boston
Trimble Scoops Up ThingMagic, Resolvyx Sells Option to Celtic Therapeutics, GSK Venture Arm Puts $4M into Dicerna, & More Boston-Area Deals News	Rebecca Zacks	10/27/10	Boston
Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News	Erin Kutz	10/22/10	Boston
Dicerna Pharmaceuticals Secures $4,000,000 Series B Round	VentureDeal	10/22/10	Boston
Dicerna Gets Glaxo’s SR One to Join Investor Syndicate	Ryan McBride	10/21/10	Boston
Dicerna, Actifio Headline Top 10 Third Quarter VC Deals in Massachusetts	Gregory T. Huang	10/18/10	Boston
Alkermes Drug Approved for Opioid Addiction, Genzyme Faces Shareholder Lawsuits, NinePoint Gets $33M, & More Boston-Area Life Sciences News	Erin Kutz	10/15/10	Boston
Mike Huckman, Former CNBC Reporting Ace, Joins Stellar Lineup at Boston’s War on Cancer	Luke Timmerman	10/14/10	Boston
Where Will the Next Gleevec Come From? Xconomy Forum Looks At the Edge of Cancer R&D	Luke Timmerman	10/05/10	Boston
August Startup Financings in MA Rose Slightly to $143M, With Plenty of Smaller Deals	Erin Kutz	09/21/10	Boston
Fierce 15 Shines Light on Some of Our Favorite Companies in Boston and Beyond	Luke Timmerman	09/15/10	National
Who Knew? Part 3: Xconomy Uncovers Even More Strange-But-True Facts About Boston’s Innovation Leaders	Robert Buderi	09/14/10	Boston
IBM Buys Unica, A123 Spinout Raises $10M, Zynga Acquires Conduit, & More Boston-Area Deals News	Erin Kutz	08/18/10	Boston
Former Sirtris Execs Sell Resveratrol Via New Nonprofit, Dicerna Closes $25M Deal, ViThera Combats Gut Disease With Engineered Bacteria, & More Boston-Area Life Sciences News	Rebecca Zacks	08/13/10	Boston
Dicerna Pharmaceuticals Garners $25,000,000 Series B Funding	VentureDeal	08/11/10	Boston
Biogen Names CEO, Glaser Leaves Partners, SV Closes $523M Fund, & More Boston-Area Life Sciences News	Erin Kutz	07/02/10	Boston
$5M Debt Deal for Dicerna Pharma	Ryan McBride	06/30/10	Boston
Dicerna Pharmaceuticals Lands $5,000,000 New Financing	VentureDeal	06/30/10	Boston
Oxford’s Fambrough Leaves for Dicerna, Clinical Data Aims to Take on Big Pharma with Antidepressants, Genzyme’s Termeer Courts Shareholders, & More Boston-Area Life Sciences News	Erin Kutz	05/14/10	Boston
Doug Fambrough Reduces Role at Oxford Bioscience Partners, Becomes CEO of Portfolio Company Dicerna Pharma	Ryan McBride	05/06/10	Boston
Avila Gets Leukemia & Lymphoma Society Funding, Dicerna Unites with Ipsen, Rhythmia to Test Heart Mapping Technology, Amag Licenses to Takeda, & More Boston-Area Life Sciences News	Erin Kutz	04/02/10	Boston
$10M for Akorri, $52M for Dyax, A New Partner for Dicerna, & More Boston-Area Deals News	Rebecca Zacks	03/31/10	Boston
Dicerna Inks Deal With Ipsen, Second RNAi Partnership of 2010	Luke Timmerman	03/30/10	Boston
Mullen to Relinquish Biogen Idec Reins, Joule to Test Ethanol Tech, Dicerna to Team with Kyowa Hakko Kirin, & More Boston-Area Life Sciences News	Rebecca Zacks	01/06/10	Boston
Dicerna Snags Deal With Japan’s Kyowa Hakko Kirin to Develop RNAi Cancer Treatments	Luke Timmerman	01/04/10	Boston
Cequent Pharmaceuticals, With First Oral RNAi Drug Soon to Enter Humans, Raises $3.4M	Luke Timmerman	10/30/09	Boston
$8M More for Acquia, Novartis-Alnylam Collaboration Continues, Virtualization Firm Akiba Acquires $6.53M, & More Boston-Area Deals News	Rebecca Zacks	07/24/09	Boston
Page 1 of 2	next page »

Entry

Author

Date

Location

Boston Xconomists and Area Innovators Gather for Special Xconomy Event: The Photos

Erin Kutz

10/13/11

Boston

Tokai Snaps Up $23M From Novartis and Apple Tree to Challenge Leaders in Prostate Cancer

Luke Timmerman

09/20/11

Boston